Glen is a qualified Pharmacist with over 30 years’ experience in the pharmaceutical and healthcare sector, in a variety of technical, legal and commercial roles. He is named inventor on over 20 patents and his expertise covers the whole pathway of innovation through prosecution and enforcement/defence. Before founding Savantium Ltd in January 2009, he was IP Manager at Vectura plc and previously Director of IP at Quadrant Drug Delivery Limited where he managed a portfolio of over 80 patent families and was instrumental in its expansion including over 50 US granted patents in 8 years. He obtained a 2(i) in Pharmacy from the University of Nottingham and completed his pre-registration training at Moorfield’s Eye Hospital, London, after working at Boots Healthcare International as a formulator.
Glen’s technical input enabled me to obtain issuance of an important U.S. patent for a pharmaceutical company. He is a pleasure to work with, responsive and highly qualified.
We have worked with Glen Martyn on a number of projects, including contentious matters and the development of patent portfolios, and his depth of technical knowledge and commercial acumen certainly helped us achieve good results for the clients concerned.
I have worked with Glen over the past three years. He helped us on various patent prosecution matters. His expertise and thorough understanding of the subject matters, especially patent prosecution on biologicals and device/drug combination, have been extremely helpful for us. I would work with him again if given such opportunity.
Min Ding, Ph.D. Vice President, Innovation Leader Preclinical & Corp. Counsel, The Medicines Company, USA
Savantium were the driving force in converting our US patent application to grant. They were able to re-align the patent requirements with our current commercial offering. This was necessary because the process took so long with the predecessors that our products had changed. Savantium were also an extremely effective part of the team with our similarly stalled European patent, which has now been granted.
I have always found Glen Martyn to be a very effective analyst of a patent landscape, with particular expertise in ensuring that the patents in a portfolio provide maximum commercial benefit for the patent holder. He is also a valuable member of the team for EPO post-grant oppositions, when it is often necessary to redraft patent claims on the hoof.
I have worked with Savantium for about 2 years now, and am impressed both by the outstanding quality of their work as well as their involvement and commitment to our projects.
Welcome to our fresh, new website, which reflects our fresh perspective on the interface between IP. R&D, legal and commercial functions, as well as presents our unique capabilities. We are also introducing a new service, believed to be the first of its kind from an IP consultancy - an instant advice portal via a "live chat" box. Please feel free to pass on any comments or feedback about our new look, as well as any suggestions on how we may improve our services to you or your clients.
New Lloyds Bank Business Insurance Report mentions IP as a business-critical asset that should be protected
A new report by Lloyds Bank Business Insurance has found that there were 20 % more businesses in the East Midlands region in 2016 compared to 2010, with growth of 37 % in the professional, scientific and technical sector. Damien McGarrigle, head of business insurance at Lloyds Bank Business Insurance, said: "Our report has uncovered strong business growth in the East Midlands over the past seven years. Getting the right advice will help start-ups get off to a flying start and safeguard their businesses to avoid being exposed to potentially irreversible damage....a business' key assets can be anything from data to intellectual property, along with materials and machinery, so these business-critical assets should be protected."
If you wish to discuss your IP needs, or if you want to help identify any, then please do get in touch.
